Related Experiment Video

Updated: May 20, 2026

Reverse Genetics Mediated Recovery of Infectious Murine Norovirus
13:48

Reverse Genetics Mediated Recovery of Infectious Murine Norovirus

Published on: June 24, 2012

Favipiravir (T-705) inhibits in vitro norovirus replication

J Rocha-Pereira1, D Jochmans, K Dallmeier

  • 1Laboratório de Microbiologia, Departamento de Ciências Biológicas, Faculdade de Farmácia, Universidade do Porto, Rua de Jorge Viterbo Ferreira n.° 228, 4050-313 Porto, Portugal.

Biochemical and Biophysical Research Communications
|July 20, 2012
PubMed

Insights

Favipiravir (T-705) effectively inhibits murine norovirus replication in laboratory settings. This antiviral shows promise for treating norovirus infections by targeting viral RNA synthesis.

Area of Science:

  • Virology
  • Antiviral drug development
  • Gastroenterology

Background:

  • Human noroviruses are a leading cause of foodborne gastroenteritis worldwide.
  • There is a critical need for effective treatments and preventative measures against norovirus infections.

Purpose of the Study:

  • To investigate the antiviral activity of Favipiravir (T-705) against murine norovirus.
  • To identify the stage of viral replication targeted by Favipiravir.

Main Methods:

  • In vitro studies were conducted to assess Favipiravir's effect on murine norovirus replication.
  • Time-of-drug addition experiments were performed to determine the mechanism of action.

Main Results:

  • Favipiravir demonstrated significant inhibition of murine norovirus replication in vitro.
  • The drug's activity was observed during the viral RNA synthesis phase, suggesting polymerase inhibition.

Conclusions:

  • Favipiravir (T-705) is a potent inhibitor of murine norovirus replication.
  • The findings support the hypothesis that Favipiravir targets the viral polymerase, offering a potential therapeutic strategy for norovirus infections.

More Related Videos

Alternative In Vitro Methods for the Determination of Viral Capsid Structural Integrity12:57

Alternative In Vitro Methods for the Determination of Viral Capsid Structural Integrity

Published on: November 16, 2017

Assays for the Identification of Novel Antivirals against Bluetongue Virus12:02

Assays for the Identification of Novel Antivirals against Bluetongue Virus

Published on: October 11, 2013

Related Concept Videos

Inhibitors of Viral Protein Synthesis01:30

Inhibitors of Viral Protein Synthesis

Protein synthesis is indispensable for viral replication, as viruses lack the cellular machinery required for this process and must hijack the host's translational apparatus. In response, host cells deploy a critical innate immune defense involving interferons, specialized cytokines that play a central role in inhibiting viral propagation.Upon viral detection, infected cells release interferons that bind to receptors on adjacent uninfected cells, activating the JAK-STAT signaling pathway and...
Viruses with RNA Genomes01:29

Viruses with RNA Genomes

RNA viruses are categorized into positive-strand, negative-strand, or double-stranded groups based on their genomic structure and replication mechanisms. This classification dictates how they exploit host cellular machinery for protein synthesis and replication. Some RNA viruses also utilize reverse transcription as part of their life cycle, further diversifying their replication strategies.Positive-Strand RNA VirusesPositive-strand RNA viruses have genomes that function directly as messenger...
Subviral Agents01:29

Subviral Agents

Subviral agents are infectious entities that resemble viruses but lack one or more viral components, such as a capsid or essential replication machinery. These agents include viroids, prions, and satellites, each possessing distinct structural and functional characteristics that influence their mode of infection and replication.Viroids are the simplest subviral agents, consisting of circular, single-stranded RNA molecules without a protein coat. They exclusively infect plants, relying entirely...